Mexico and Argentina call for no country in Latin America to run out of coronavirus vaccines

The governments of Mexico and Argentina called on Wednesday that no country in Latin America be left without access to vaccines against coronavirus covid-19, in a joint statement issued after the visit of the Argentine president, Alberto Fernández.

“The COVID-19 pandemic has highlighted the importance of keeping Latin America and the Caribbean strong, united and in solidarity, where no country in the region is excluded from universal, fair, equitable and timely access to medicines, vaccines and supplies doctors ”, the document says.

• The WHO did not recognize the effectiveness of ivermectin against covid-19; still in study
• America expresses its dissatisfaction with the slow delivery of vaccines against the coronavirus
• PAHO on the coronavirus in America: “We are not out of danger yet”

Both governments added that they will continue to collaborate “For the region to achieve self-sufficiency in the production of vaccines and that these are considered as global common goods, as well as their patents.”

The call echoes the demand that both governments made before for equitable access to vaccines against covid-19 in the world.

On Tuesday, Fernández said that he would invite Mexico to join an initiative that he will propose with France at the G-20 so that the vaccine is declared a global good so that all countries can produce it freely.

For his part, the Mexican president, Andrés Manuel López Obrador, called for a more determined intervention from the UN to guarantee that all countries have access to the vaccine.

Mexico and Argentina collaborate with AstraZeneca in the production of around 200 million doses of the vaccine against covid-19 developed by the University of Oxford that will be sold in the Latin American market.

Argentina It is in charge of the production of the active substance while Mexico of the packaging.

With the joint statement, Fernández’s three-day visit to Mexico culminates, in which he also visited the Liomont laboratory, where the AstraZeneca vaccine is packaged.